ENDLOS-TURBO PUT - AMGEN | Market Closed - Deutsche Boerse AG 03:34:47 2024-06-18 pm EDT | ||
| 2.65 EUR | -7.99% |
|
| Current month | -5.02% | ||
| 1 month | +31.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 2.65 | -7.99% |
| 24-06-17 | 2.88 | -14.54% |
| 24-06-14 | 3.37 | +0.30% |
| 24-06-13 | 3.36 | +4.67% |
| 24-06-12 | 3.21 | +3.22% |
Delayed Quote Deutsche Boerse AG
Last update June 18, 2024 at 03:34 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2WA1 |
| ISIN | DE000DJ2WA18 |
| Date issued | 2023-10-04 |
| Strike | 333.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.367 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.27 € |
|---|---|
| Lowest since issue | 0.99 € |
| Spread | 0.02 € |
| Spread % | 0.75% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306
USD
Average target price
316.4
USD
Spread / Average Target
+3.42%
- Stock Market
- Certificates
- Certificat
